Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome. Biomol Biomed [Internet]. 2025 Apr. 3 [cited 2025 May 2];25(5):1175–1183. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11564